Content about Colorectal cancer

February 20, 2014

Ferndale Healthcare recently announced a three-year partnership on behalf of its RectiCare (lidocaine 5%) Anorectal Cream brand and the Colon Cancer Alliance.

FERNDALE, Mich. — Ferndale Healthcare recently announced a three-year partnership on behalf of its RectiCare (lidocaine 5%) Anorectal Cream brand and the Colon Cancer Alliance. This nonprofit corporation is the nation’s leading patient advocacy organization dedicated to increasing colon cancer screening rates and survivorship.

February 4, 2014

Salix Pharmaceuticals announced that the Food and Drug Administration has accepted for filing a new drug application for Budesonide 2 mg Rectal Foam for the induction of remission in patients with active mild to moderate distal ulcerative colitis extending up to 40 cm from the anal verge.

RALEIGH, N.C. — Salix Pharmaceuticals last week announced that the Food and Drug Administration has accepted for filing a new drug application for Budesonide 2 mg Rectal Foam for the induction of remission in patients with active mild to moderate distal ulcerative colitis extending up to 40 cm from the anal verge.

The FDA has issued an action date of Sept. 15, 2014 under the Prescription Drug User Fee Act. 

March 15, 2013

A record number of people were motivated to seek colon cancer screenings for a day last week, according to an organization focused on the disease.

NASHVILLE, Tenn. — A record number of people were motivated to seek colon cancer screenings for a day last week, according to an organization focused on the disease.

StopColonCancerNow.com designated March 8 as National Colon Cancer Screening Day, motivating more 2,000 new patients to seek screenings for the disease. Experts recommend that anyone older than 50 years, as well as African-Americans 45 years and older and those who have a family history of polyps or colon cancer, get a colonoscopy.

March 13, 2013

Actress Meryl Streep will encourage people to get screened for colorectal cancer in a new series of public service announcements from the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and the Centers for Disease Control and Prevention, the groups said Wednesday.

LOS ANGELES — Actress Meryl Streep will encourage people to get screened for colorectal cancer in a new series of public service announcements from the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and the Centers for Disease Control and Prevention, the groups said Wednesday.

March 8, 2013

Navarro Discount Pharmacy is promoting colon cancer screenings in the month of March under a partnership with a group focused on the disease, Navarro said Friday.

MIAMI — Navarro Discount Pharmacy is promoting colon cancer screenings in the month of March under a partnership with a group focused on the disease, Navarro said Friday.

The regional retail pharmacy has partnered with StopColonCancerNow.com to promote the screenings, which screening guidelines advise adults older than 50 years to receive, or 45 years if they are African-American. According to the American Cancer Society, the five-year survival rate for colon cancer is 90% when detected and treated in the earliest stage.

February 12, 2013

The Colon Cancer Challenge Foundation, a nonprofit organization dedicated to reducing colorectal cancer incidence and death throughout the United States, presented Sanofi with its annual Blue Star Corporate Award.

NEW YORK — Sanofi US was named corporate partner of the year by the Colon Cancer Challenge Foundation (CCCF), a nonprofit organization dedicated to reducing colorectal cancer incidence and death throughout the United States, and presented with CCCF's annual Blue Star Corporate Award.

January 25, 2013

The Food and Drug Administration has approved a new use for a cancer drug made by Roche unit Genentech, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new use for a cancer drug made by Roche unit Genentech, the agency said.

The FDA announced the approval of Avastin (bevacizumab) combined with fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin chemotherapy for treating colorectal cancer that has spread to other parts of the body, also known as metastatic colorectal cancer, or mCRC.

The drug is also approved for treating lung cancer, kidney cancer and brain cancer.

October 25, 2012

Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist.

 BIRMINGHAM, Ala. — Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist. In a study that appears in the same issue, researchers examined the use of aspirin in the treatment outcomes of patients with colorectal cancer.

September 27, 2012

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

SAN FRANCISCO — The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

Bayer and Onyx Pharmaceuticals announced the approval of Stivarga for colorectal cancer that has spread to other parts of the body, also known as metastatic CRC, specifically for those patients who have received treatment with currently available therapies.

Bayer developed the drug and will pay royalties to Onyx on future global net sales of the drug for cancer. The two companies will promote the drug together in the United States.

September 19, 2012

The Undy 5000 5K Run/Walk, presented by Dulcolax, returned to Philadelphia for the fifth consecutive year to help raise funds for colon cancer research.

PHILADELPHIA — The Undy 5000 5K Run/Walk, presented by Dulcolax, returned here for the fifth consecutive year to help raise funds for colon cancer research. Almost 1,000 participants ran in their underwear as a tongue-in-cheek reference to the area affected by colon cancer, raising $120,000 for Colon Cancer community programs.

The Philadelphia Undy 5000 featured the Colon Cancer Alliance’s Inflatable Colon; a giant, walk-through colon that shows the various stages of colon cancer, including descriptions about Crohn’s disease and Colitis. 

August 13, 2012

A large new observational study published Friday found more evidence of an association between daily aspirin use and modestly lower cancer mortality, but suggested any reduction may be smaller than that observed in a recent analysis. The study appeared online in the Journal of the National Cancer Institute.

ATLANTA — A large new observational study published Friday found more evidence of an association between daily aspirin use and modestly lower cancer mortality, but suggested any reduction may be smaller than that observed in a recent analysis. The study appeared online in the Journal of the National Cancer Institute.

August 6, 2012

The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

July 31, 2012

The 2012 Jersey Shore Undy 5000 raised more than $80,000 for local and national colon cancer screening, awareness and support programs, Boehringer-Ingelheim — which sponsored the event under its Dulcolax brand — announced Saturday.

LONG BRANCH, N.J. — The 2012 Jersey Shore Undy 5000 raised more than $80,000 for local and national colon cancer screening, awareness and support programs, Boehringer-Ingelheim — which sponsored the event under its Dulcolax brand — announced Saturday.

July 9, 2012

The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.

NEW YORK — The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.

Lilly and Bristol announced the approval of Erbitux (cetuximab) for treating colorectal cancer that is KRAS mutation-negative, expresses the epidermal growth factor receptor and has spread to other parts of the body, also known as metastasis. The drug is approved for use alongside a chemotherapy combination containing irinotecan, 5-fluorouracil and leucovorin, also known as FOLFIRI.

June 4, 2012

An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

WAYNE, N.J. — An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

May 24, 2012

Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.

SOUTH SAN FRANCISCO, Calif. — Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.

Onyx Pharmaceuticals announced that Bayer HealthCare had submitted a regulatory approval application to the Food and Drug Administration for regorafenib in patients with metastatic colorectal cancer.

March 23, 2012

Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

LONDON — Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

March 15, 2012

In line with National Colorectal Cancer Awareness Month, Winn-Dixie is offering customers the chance to pick up a free test at its pharmacies.

JACKSONVILLE, Fla. — In line with National Colorectal Cancer Awareness Month, Winn-Dixie is offering customers the chance to pick up a free test at its pharmacies.

December 1, 2011

A new study conducted by researchers at Yeshiva University's Albert Einstein College of Medicine found that high blood-sugar levels may be associated with an increased risk of colorectal cancer.

BRONX, N.Y. — A new study conducted by researchers at Yeshiva University's Albert Einstein College of Medicine found that high blood-sugar levels may be associated with an increased risk of colorectal cancer.

Researchers examined the fasting blood sugar and insulin levels of nearly 5,000 postmenopausal women — all of whom were enrolled in the National Institutes of Health's landmark Women's Health Initiative study — several times over a 12-year period.

November 18, 2011

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

SILVER SPRING, Md. — A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

November 7, 2011

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for treating head and neck cancer, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb and Eli Lilly & Co. for treating head and neck cancer, the agency said Monday.

The FDA announced the approval of Erbitux (cetuximab) for use with chemotherapy in treating head and neck cancer that had spread to other parts of the body. The drug originally was approved in 2004 for treating certain cases of late-stage colon cancer in patients who had stopped responding to chemotherapy.

October 31, 2011

Sam's Club is offering a free digestive health screening this month.

BENTONVILLE, Ark. — Sam's Club is offering a free digestive health screening this month.

October 13, 2011

New research published in the October 2011 issue of Harvard Men's Health Watch suggested aspirin may play a role in fighting cancer, the publication announced Wednesday.

BOSTON — New research published in the October 2011 issue of Harvard Men's Health Watch suggested aspirin may play a role in fighting cancer, the publication announced Wednesday.

October 4, 2011

More than three-quarters of cancer patients have insufficient levels of vitamin D, and the lowest levels are associated with more advanced cancer, according to a study presented Oct. 2 at the 53rd Annual Meeting of the American Society for Radiation Oncology.

MIAMI BEACH, Fla. — More than three-quarters of cancer patients have insufficient levels of vitamin D, and the lowest levels are associated with more advanced cancer, according to a study presented Oct. 2 at the 53rd Annual Meeting of the American Society for Radiation Oncology.

September 26, 2011

Despite flooding from severe weather in several parts of Pennsylvania earlier this month, nearly 600 people ran in their underwear in Philadelphia in support of those who have been affected by colon cancer.

PHILADELPHIA — Despite flooding from severe weather in several parts of Pennsylvania earlier this month, nearly 600 people ran in their underwear in Philadelphia in support of those who have been affected by colon cancer.

Participants of the Fourth Annual Philadelphia Undy 5000 5K Run/Walk ran on MLK Drive, near the Philadelphia Museum of Art, and raised just over $110,000 to fight colon cancer.